Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 572.5K | -- | 3.25% | +536.6K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 543.1K | -- | 3.09% | +299.4K | 2026-06-30 |
| CITADEL ADVISORS LLC | 198.5K | -- | 1.13% | +186.7K | 2026-06-30 |
| MAI Capital Management | 108.3K | -- | 0.62% | +17.0K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 88.2K | -- | 0.50% | +2.9K | 2026-06-30 |
| COMMONWEALTH EQUITY SERVICES, LLC | 51.4K | -- | 0.29% | -- | 2026-06-30 |
| HRT FINANCIAL LP | 51.2K | -- | 0.29% | +39.6K | 2026-06-30 |
| VANGUARD FIDUCIARY TRUST CO | 49.0K | -- | 0.28% | -- | 2026-06-30 |
| BlackRock, Inc. | 43.3K | -- | 0.25% | -- | 2026-06-30 |
| BANK OF AMERICA CORP /DE/ | 40.9K | -- | 0.23% | -81 | 2026-06-30 |
